Common Contracts

EX-10.1 3 d452677dex101.htm EX-10.1 SHARE PURCHASE AGREEMENT AND OMNIBUS AMENDMENT

Share Purchase Agreement • May 5th, 2020 • New York

• Contract Type
  Share Purchase Agreement
• Filed
  May 5th, 2020
• Jurisdiction
  New York

This Share Purchase Agreement and Omnibus Amendment (this “Agreement”) is dated as of September 21, 2017, by and among Juno Therapeutics, Inc., a Delaware corporation (the “Company”), Celgene Corporation (“Celgene Corp.”), Celgene Switzerland LLC (“Celgene Switzerland”) and Celgene RIVOT Ltd (“Celgene RIVOT” and together with Celgene Corp. and Celgene Switzerland, the “Celgene Parties”).

SHARE PURCHASE AGREEMENT AND OMNIBUS AMENDMENT

Share Purchase Agreement • September 22nd, 2017 • Juno Therapeutics, Inc. • Biological products, (no disgnostic substances) • New York

• Contract Type
  Share Purchase Agreement
• Filed
  September 22nd, 2017
• Company
  Juno Therapeutics, Inc.
• Industry
  Biological products, (no disgnostic substances)
• Jurisdiction
  New York

This Share Purchase Agreement and Omnibus Amendment (this “Agreement”) is dated as of September 21, 2017, by and among Juno Therapeutics, Inc., a Delaware corporation (the “Company”), Celgene Corporation (“Celgene Corp.”), Celgene Switzerland LLC (“Celgene Switzerland”) and Celgene RIVOT Ltd (“Celgene RIVOT” and together with Celgene Corp. and Celgene Switzerland, the “Celgene Parties”).